KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Cardlytics (CDLX) EPS (Weighted Average and Diluted) (2017 - 2025)

Cardlytics' EPS (Weighted Average and Diluted) history spans 8 years, with the latest figure at -$0.14 for Q4 2025.

  • For Q4 2025, EPS (Weighted Average and Diluted) rose 44.0% year-over-year to -$0.14; the TTM value through Dec 2025 reached -$1.94, up 48.95%, while the annual FY2025 figure was -$1.95, 50.13% up from the prior year.
  • EPS (Weighted Average and Diluted) reached -$0.14 in Q4 2025 per CDLX's latest filing, up from -$1.36 in the prior quarter.
  • In the past five years, EPS (Weighted Average and Diluted) ranged from a high of $0.91 in Q1 2022 to a low of -$11.32 in Q4 2022.
  • Average EPS (Weighted Average and Diluted) over 5 years is -$1.42, with a median of -$0.63 recorded in 2023.
  • Peak YoY movement for EPS (Weighted Average and Diluted): skyrocketed 207.06% in 2022, then plummeted 431.58% in 2023.
  • A 5-year view of EPS (Weighted Average and Diluted) shows it stood at -$1.35 in 2021, then plummeted by 738.52% to -$11.32 in 2022, then surged by 75.8% to -$2.74 in 2023, then skyrocketed by 90.88% to -$0.25 in 2024, then soared by 44.0% to -$0.14 in 2025.
  • Per Business Quant, the three most recent readings for CDLX's EPS (Weighted Average and Diluted) are -$0.14 (Q4 2025), -$1.36 (Q3 2025), and -$0.18 (Q2 2025).